Tag

Bundibugyo Virus Disease

All articles tagged with #bundibugyo virus disease

health1 month ago•12 min saved

Bundibugyo Ebola Outbreak Expands Across DRC, Uganda Faces Cross-Border Risk

WHO reports the Bundibugyo virus disease outbreak in the DRC has expanded to 61 health zones across six provinces, with 6,757 confirmed cases and 3,267 deaths (CFR 48.3%) as of 7 September 2026; Uganda has 20 cases and one in France, with 1,611 recoveries. The epidemic shows ongoing geographic spread and high fatality in some areas (e.g., North Kivu ~65%). Public health actions include intensified surveillance, cross-border coordination, and vaccination of frontline workers (Ervebo used only under research; 2,007 vaccinated by 6 Sept). A clinical trial (PARTNERS) for treatments is underway, and WHO continues to advise against travel restrictions while urging IPC, safe burials, and community engagement in a complex humanitarian setting.

via World Health Organization (WHO)|

#bundibugyo-virus-disease #cross-border-transmission #democratic-republic-of-the-congo

health1 month ago•4 min saved

Deadliest Ebola Outbreak in DR Congo Tests Health Systems Amid Conflict

A Bundibugyo virus outbreak in DR Congo’s Ituri Province has become the deadliest Ebola outbreak in the country’s history, with over 4,900 confirmed cases and more than 2,300 deaths. The virus spread before official declaration on May 15, and there are no licensed vaccines or specific treatments for Bundibugyo, leaving containment to early detection, supportive care, infection prevention, and community engagement. Response is hampered by armed conflict, difficult access, and mistrust, though lab capacity in Ituri has expanded to aid case confirmation and surveillance.

via Al Jazeera|

#bundibugyo-virus-disease #drc #ebola

health4 months ago•15 min saved

CDC models warn Bundibugyo Ebola outbreak could rival West Africa if not swiftly contained

CDC used a branching-process model, calibrated to May 24, 2026 deaths, to project Bundibugyo virus disease outbreaks over 90 days under four isolation scenarios (20–95%). Without high isolation, simulations frequently produced very large outbreaks (>20,000 cases); with 70% isolation, most projections stay under 10,000 cases and 4,000 deaths. The study underscores that rapid, large-scale public health actions—rapid case finding, isolation, contact tracing, and safe burials—are needed to prevent the outbreak from becoming one of the largest Ebola epidemics in history.

via Centers for Disease Control and Prevention | CDC (.gov)|

#bundibugyo-virus-disease #ebola #health

health4 months ago•9 min saved

Bundibugyo Ebola Outbreak Expands Across DRC and Uganda, WHO Warns

The WHO reports a rapidly evolving Bundibugyo virus disease outbreak in the Democratic Republic of the Congo and Uganda, with 906 suspected cases and 223 deaths in DRC and 134 confirmed cases (nine in Uganda) with 18 deaths as of 29 May 2026. Transmission remains concentrated in Ituri, North Kivu and South Kivu, and cross-border spread, insecurity, and gaps in isolation and follow-up complicate response. A U.S. physician treating patients in DRC tested positive and is being treated in Germany. Public health measures include rapid response teams, enhanced surveillance, lab confirmation, infection prevention and control, safe treatment centers, and community engagement; there are no approved vaccines or specific treatments. WHO assessed national risk as very high in DRC, high regionally, and low globally, and urged coordinated outbreak control and sustained surveillance with no travel restrictions for now.

via World Health Organization (WHO)|

#bundibugyo-virus-disease #cross-border-transmission #democratic-republic-of-the-congo

health4 months ago•10 min saved

WHO prioritizes Bundibugyo Ebola countermeasures and calls for rapid clinical trials

WHO convened expert groups to evaluate candidate vaccines and therapeutics for Bundibugyo virus disease (BDV) outbreaks in the Democratic Republic of the Congo and Uganda. With no BDV-specific licensed treatments or vaccines, experts prioritized three therapeutics for evaluation in clinical trials—MBP134, Maftivimab, and remdesivir—with combination therapy also considered, and looked at obeldesivir for post‑exposure prophylaxis. The most promising BDV vaccine candidates are a single‑dose rVSV Bundibugyo vaccine (7–9 months to readiness for trials) and ChAdOx1 Bundibugyo (2–3 months to efficacy testing), while Ervebo should not be used outside carefully designed research settings to assess BDV protection. The initiative emphasizes ethics, rapid trial design, accelerated access to supplies, and strengthened outbreak control as trials proceed.

via World Health Organization (WHO)|

#bundibugyo-virus-disease #clinical-trials #ebola-vaccines